Obtenção de fibras de poli (ácido lático): cerâmica para aplicação em sistemas de liberação prolongada da cloxacilina
Abstract
The excessive consumption of these drugs can
cause the development of superbugs capable of resisting treatments in humans, in
addition to environmental consequences. Among the alternatives used, fibers obtained by
electrospinning stand out as a simple and low cost strategy, increasing the bioavailability
of an active principle at an infected site, for example, reaching therapeutic levels with a
single dose. Thus, the objective of this work was to obtain fiber polylactic acid: starch: clay
for controlled / prolonged drug release. The fibers were produced using electrospinning
technique in which four different systems were developed: polylactic acid; polylactic acid
and starch; polylactic, starch and laponite; polylactic acid, starch and montmorillonite.
However, for each system developed, benzathine and sodium cloxacillin were tested.
Bactericidal tests were carried out with all samples against the bacteria S. aureus and E.
coli. In addition, mechanical analysis of the developed systems was carried out. The
release tests were carried out in buffered pH 7 solutions and the drugs were quantified
with the aid of an ultraviolet-visible spectrophotometer. The results indicated that the fibers
of the polylactic acid starch and montmorillonite system showed higher values of tension
and deformation, approximately 4 times, when compared to the polylactic acid fibers. In
the release tests, controlled/prolonged release profiles were observed, by adding clays,
laponite and montmorillonite, which were adjusted by the Korsmeyer-Peppas model. In
the other systems, burst release profiles were observed. Microbiological tests for these
systems, using benzathine and sodium cloxacillin, have shown bactericidal activity against
the bacterium S. aureus. Therefore, systems that contain clays are promising for
application involving the release of cloxacillins, especially those that require dosage,
whose concentration remains for a long time in the therapeutic range of this medication
Collections
The following license files are associated with this item: